(MENAFN- PR Newswire) NEW YORK, Jan. 25, 2023 /PRNewswire/ -- DoubleVerify Holdings Inc. (NYSE: dv ) will replace Meridian Bioscience Inc. (NASD: VIVO) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, January 31. SD Biosensor is acquiring Meridian Bioscience in a deal expected to be completed soon pending final conditions.
Following is a summary of the change that will take place prior to the open of trading on the effective date:
Effective Date | Index Name
| Action | Company Name | Ticker | GICS Sector |
January 31, 2023 | S&P SmallCap 600 | Addition | DoubleVerify Holdings | DV | Information Technology |
| S&P SmallCap 600 | Deletion | Meridian Bioscience | VIVO | Health Care |
For more information about S&P Dow Jones Indices, please visit
ABOUT S&P DOW JONES INDICES S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.
S&P Dow Jones Indices is a division of S&P Global (NYSE: spgi ), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit .
FOR MORE INFORMATION: S&P Dow Jones Indices
[email protected]
Media Inquiries
[email protected]
SOURCE S&P Dow Jones Indices
MENAFN25012023003732001241ID1105477764
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.